What Enzyme Communications say about themselves
“We're an agency specialising in science communication and marketing - we help the medical and scientific industries make the complex consumable.”
Enzyme Communications Ltd
- Incorporated
- 26 May 2017 (9 years)
- Industry
- Public relations and communications activities (70210) Other human health activities (86900)
- Directors
- Owned by
- Accounts type
- Small
- Region
- North West
- Address
- Suite AGreenway House Larkwood WayTytherington Business ParkMacclesfieldSK10 2XR
Website & contact details
- Website
Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 8 June 2027
- Last conf. stmt
- 25 May 2026
Charges
- Total
- 2
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 26 April 2024
British
Born December 1984 (41)
Director · Appointed 26 April 2024
British
Born September 1973 (53)
Officer history (3 former)
26 April 2024
26 April 2024
26 April 2024
Resigned Goodband, Adam Garry, Mr. as Director
26 April 2024
Resigned Kumar, Neil William, Mr. as Director
8 February 2022
Resigned Wallach, Jacqueline Beatrice as Director
18 April 2018
Appointed Wallach, Jacqueline Beatrice as Director
18 April 2018
Appointed Goodband, Adam Garry, Mr. as Director
26 May 2017
Appointed Kumar, Neil William, Mr. as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 26 April 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 13216692
Former controllers (3)
26 April 2024
Ceased Neil William Kumar — Owns 25–50% of shares
26 April 2024
Ceased Adam Garry Goodband — Owns 25–50% of shares
8 February 2022
Ceased Jacqueline Beatrice Wallach — Owns 25–50% of shares
Group structure 13 shown
Ownership group derived from the Companies House PSC register
Bioscript Limited Owns 75–100% of shares
Azimuth Pharma Limited Owns 75–100% of shares
Fortis Pharma Consulting Limited Owns 75–100% of shares
Bioscript Group Limited Owns 75–100% of shares
Bioscript Stirling Limited Owns 75–100% of shares
Medologie Limited Owns 75–100% of shares
Enzyme Communications Ltd This company Owns 75–100% of shares
Meridian Healthcomms Holdings Limited Owns 75–100% of shares
Cancer Communications and Consultancy Limited Owns 75–100% of shares
Meridian Healthcomms Limited Owns 75–100% of shares
Triducive Partners Limited Owns 75–100% of shares
Valid Insight Ltd Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £387,577
- Cash
- £585,620
- Turnover
- £1,460,457
- Profit Before Tax
- £396,379
- Employees
- 14
- Debt Ratio
- 66%
- Current Ratio
- 1.5x
- Profit Margin
- 27%
- Return on Equity
- 93%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £18,766 | £66,471 | £44,220 | £54,521 | £14,932 | £5,456 |
| Current Assets | £1,127,427 | £1,322,399 | £1,470,024 | £1,747,273 | £744,095 | £301,019 |
| Debtors | £625,851 | £654,468 | £257,744 | £276,498 | ||
| Cash | £585,620 | £696,548 | £815,556 | £1,489,529 | £467,597 | |
| Creditors (< 1 year) | £757,591 | £398,640 | £462,491 | £564,225 | £198,420 | £47,676 |
| Net Current Assets | £369,836 | £923,759 | £1,007,533 | £1,183,048 | £545,675 | £355,293 |
| Net Assets | £387,577 | £973,612 | £1,043,351 | £1,227,210 | £557,770 | £359,749 |
| Shareholder Funds | £387,577 | £973,612 | £1,043,351 | £1,227,210 | £557,770 | £359,749 |
| Turnover | £1,460,457 | |||||
| Cost of Sales | £847,632 | |||||
| Gross Profit | £612,825 | |||||
| Admin Expenses | £229,259 | |||||
| Staff Costs | £606,864 | |||||
| Operating Profit | £383,566 | |||||
| Profit Before Tax | £396,379 | |||||
| Tax | £34,679 | |||||
| Profit for Period | £361,700 | |||||
Filings 58
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 2 July 2026 | Registration of a charge | |||
| 27 June 2026 | Accounts for a small company | 30 September 2025 | ||
| 8 June 2026 | Change of details for a person with significant control | |||
| 8 June 2026 | Confirmation statement with no updates | 25 May 2026 | ||
| 8 June 2026 | Change of details for a person with significant control |
Some other companies at this address
Other companies in this industry
Manchester
Wokingham
London
London
Marlow
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →